Clinical Trial Update: Cortisol and Nutritional Sympathetic Responsiveness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on cortisol and nutritional sympathetic responsiveness related to metabolic syndrome, obesity, and insulin resistance; status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome
• Obesity

Snippet

Sponsor: Baker Heart Research Institute | Conditions: Metabolic Syndrome, Obesity | Phase 4 | Status: UNKNOWN